{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:44:21Z","timestamp":1769064261932,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.transproceed.2011.06.044","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T08:51:22Z","timestamp":1313225482000},"page":"2253-2256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of Immunological Markers as Mediators of Graft Vasculopathy Development in Heart Transplantation"],"prefix":"10.1016","volume":"43","author":[{"given":"S.","family":"Mirabet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gelp\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Brossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Molto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Alvaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Padr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Roig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.06.044_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","article-title":"ACC\/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult","volume":"46","year":"2005","journal-title":"JACC"},{"key":"10.1016\/j.transproceed.2011.06.044_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2010.08.007","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-seven official adult heart transplant report\u20142010","volume":"29","author":"Stehlik","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib3","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.healun.2004.12.110","article-title":"2-analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy","volume":"24","author":"Poggio","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.healun.2007.10.005","article-title":"Assessment of early atheroesclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis","volume":"27","author":"K\u00f6ning","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.healun.2010.10.013","article-title":"Advances in heart transplantation: the year in review","volume":"30","author":"Shah","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001573-200403000-00019","article-title":"Cardiac allograft vasculopathy: the central pathogenic role of isquemia-induced endothelial cell injury","volume":"19","author":"Pinney","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.transproceed.2011.06.044_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/01.ATV.17.10.2115","article-title":"Sustained anti-CD4\/CD8 treatment blocks inflamatory activation and intimal thickening in mouse heart allografts","volume":"17","author":"Raisanen-Sokolowski","year":"1997","journal-title":"Arterioscler Throm Vasc Biol"},{"key":"10.1016\/j.transproceed.2011.06.044_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/01.CIR.101.9.1034","article-title":"Attenuated cardiac allogarft vasculopatrhy in mice with targeted deletion of the transcription factor STAT4","volume":"101","author":"Koglin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2011.06.044_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.healun.2004.05.014","article-title":"Peripheral expansion of circulating T-helper 1 cells predicts coronary endothelial dysfunction after cardiac transplantation","volume":"24","author":"Methe","year":"2005","journal-title":"J Heart lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.transproceed.2011.06.044_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1172\/JCI200423238","article-title":"Tregs and transplantation tolerance","volume":"114","author":"Walsh","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transproceed.2011.06.044_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+ CD25+ FoxP3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.transproceed.2011.06.044_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.transproceed.2011.06.044_bib14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Steward","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib15","first-page":"359","article-title":"Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients","volume":"152","author":"Raisanen-Sokolowski","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.transproceed.2011.06.044_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35003221","article-title":"Interferon gamma elicits arteriosclerosis in the absence of leukocytes","volume":"403","author":"Tellides","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2011.06.044_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart Lung Transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Hunt","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib18","doi-asserted-by":"crossref","first-page":"s207","DOI":"10.1016\/j.healun.2004.03.010","article-title":"Optimizing the immunosuppressive regimen in heart transplantation","volume":"23","author":"Eisen","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.044_bib19","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.1016\/j.transproceed.2005.02.118","article-title":"Improving outcomes in heart transplantation: the potential of proliferation signals inhibitors","volume":"37","author":"Eisen","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.06.044_bib20","doi-asserted-by":"crossref","first-page":"s191","DOI":"10.1016\/j.healun.2005.01.012","article-title":"Prevention of cardiac allograft vasculopathy with Certican (everolimus)","volume":"24","author":"Valantine","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451100892X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451100892X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:27:37Z","timestamp":1758576457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451100892X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S004113451100892X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.06.044","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Immunological Markers as Mediators of Graft Vasculopathy Development in Heart Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}